ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SI vs CARL // EV/EBITDA & P/E VALUATION

Shoulder Innovations Inc. (NYSE) VS. Carlsmed Inc. (NASDAQ) • 15-METRIC TALLY: SI 5 — CARL 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SI VS. CARL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SI CARL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.50% 75.30% +1.20 SI /gross-margins <GO>
Return on Invested Capital (ROIC) -16.10% -35.00% +18.90 SI /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -8.46% -6.88% -1.58 CARL /fcf-yield <GO>
Operating Margin -55.60% -60.00% +4.40 SI /operating-margins <GO>
Net Profit Margin -60.00% -58.70% -1.30 CARL /net-margins <GO>
Revenue Growth (YoY) 49.60% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.73 7.83 +0.90 SI /balance-sheet <GO>
Piotroski F-Score Quality 5/9 3/9 +2.00 SI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.8 52.6 -1.82 CARL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $425.5M $430.6M -$5.0M CARL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SI REV CARL REV SI GROSS % CARL GROSS % SI FCF CARL FCF
FY 2025 $47.3M $50.5M 76.5% 75.3% -$36.0M -$29.6M
FY 2024 $31.6M $27.2M 77.0% 73.8% -$18.2M -$25.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SI // BETA —
CARL // BETA —